NCT05649852 Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy
| NCT ID | NCT05649852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Chemotherapy Effect |
| Study Type | INTERVENTIONAL |
| Enrollment | 192 participants |
| Start Date | 2023-03-23 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 192 participants in total. It began in 2023-03-23 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to assess the average of the "State Anxiety" score of the State Trait Inventory Anxiety at the end of the third cycle of chemotherapy compared to the pre-treatment score (inclusion)
Eligibility Criteria
Inclusion Criteria: * Patient with cancer treated with adjuvant chemotherapy with an interval of 14 or 21 days for the first 3 cycles; * Chemotherapy naïve patient; * Patient speaking and understanding French and able to complete the questionnaires; * Patient having been informed and having signed an informed consent form to participate in the study. Exclusion Criteria: * Patient who has already benefited from socio-aesthetic care; * Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision); * Patient unable to understand the information related to the study (linguistic, psychological, cognitive reasons, etc.); * Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding; * Patient participating in another clinical trial, or in a period of exclusion from another clinical trial; * Patient not benefiting from a social security scheme.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05649852 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chemotherapy Effect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05649852 currently recruiting?
Yes, NCT05649852 is actively recruiting participants. Contact the research team at l.doublet@ramsaygds.fr for enrollment information.
Where is the NCT05649852 trial being conducted?
This trial is being conducted at Valence, France.
Who is sponsoring the NCT05649852 clinical trial?
NCT05649852 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 192 participants.